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Conclusions: (1) The risk of I-CVA or P-CVA is higher for CABG procedures,
with or without associated valve procedure, than for isolated valve proce-
dures. (2) Patient age is a predictor for I-CVA and P-CVA. (3) There may be a
slightly increased risk for I-CVA in females.
Culprit Lesion None Graft Native Vessel
n (pts.) 15(11.8%) 66 (52.0%) 46(362%)
Age [baseline angiol (yrs) 65.5 (53-76)' 59B (45-73)' 604 (36-74)
Male gender 1'101 80 90.9 869
Time CABG-interim angio (mo) 77.1 ± 10 1026 ± 3.2' 90.3±5.1·'
Resultant PTCNCABG 1%) 010 33.3/31.8 304143
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Two prospective randomized double blind clinical trials, performed in United
Kingdom IUKI and in Italy (IT) showed that Indobufen IINB reversible cy-
clooxygenase inhibitorl is as effective as, and safer than, the association of
Aspirin plus Dipyridamole in preventing the occlusion of saphenous vein (SV)
coronary artery bypass grafts (CABG).
The power of each of the two trials was 80% for a difference in graft occlu-
sion of 10%. We present the results of the analysis, carried out by properly
combining the information given by the two trials in order to increase the
precision of the estimates both of efficacy and of safety. The analysis was
performed on total 934 patients who undervvent 1 year angiography (2258
SV distal anastomosis).
UK and IT patients had similar clinical characteristics, UK pts had higher
number of grafts per patient and smaller vessel diameters, distal anastomo-
sis occlusion rates were 19.8% (UK) and 20.9% (IT), small vessel diameter
«1.5 mm) and right coronary artery location adversely affected graft patency
in both groups.
Combined analysis showed that: al the Odds Ratio of distal anastomosis
occlusion of INB vs ASA + DIP group is: OR = 1.05 (95% CL: 0.85 - 1.291
suggesting that the efficacy of the two treatments is comparable and b) INB
had significantly fewer side effects than ASA + DIP.
Conclusions
- two multicenter CABG studies performed in different countries accruing
patients with similar clinical characteristics showed similar graft patency;
- combined analysis confirmed on a wide population that IN B is as effec-
tive as the association of ASA + DIP on graft patency and is much better
tolerated.
OM in M were: age> 70 (2.71. LVEF < 40% (2.6), OM (1.61, PVD (2.3), SMa
(1.9), renal failure (2.5), PMI (2.0) and for F the predictors were: age> 70 (2.0),
US (2.51. LV grade (3.2), PVD (2.8). The predictors of LOS in M were: age>
70 (1.6), LVEF < 40% (2.2). REDO (5.6), left main LMS (1.3), endarterectomy
EA (1.81. OM (1.6). congestive failure (2.1), PMI (2.0). LOS predictors for F
were: US (1.6), LVEF < 40% 12.5). LMS 11.71, REDO (4.2). EA (3.21.
Conclusion: Risk factors for OM and LOS were similar for males and fe-
males. Increased risk of surgery for Fmay be related to differences in method
of atherosclerosis development.
Analysis of the Culprit Lesion and Clinical Events
in Post-CABG Patients: Interim Angiographic
Results from the Post-CABG Trial
Intraoperative eVA Postoperative eVA
Risk Factor Odds Ratio p Risk Factor Odds Ratio p
Carotid Disease 481 <0.001 Prior Stroke 7.33 <0.001
Renal Disease 4.04 <0.001 Refuse blood 6.68 0003
Diabetes 262 0.003 Cardiac Arrest 6.60 <0.001
MI S 30 Days 2.50 0.103 Carotid Disease 361 0.012
Age 20 65 Years 191 0.074 Cardiogenic Shock 302 0.014
Female Gender 180 0.063 Age> 75 Years 2.05 0.041
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Clinical events prompting angiography occur in patients post bypass surgery,
and often necessitate repeat revascularization procedures. In these patients
the culprit lesion may occur in either the native vessel or the graft. The Post-
CABG study, a 5 year trial aimed at reducing SVG closure in minimally symp-
tomatic patients 1-11 years Post-CABG, offers a unique view into this prob-
lem, since this study requires an initial angiogram to document baseline graft
patency. In a subgroup of Post-CABG patients in whom symptoms prompted
an interim "clinically driven" angiogram, we compared the baseline and in-
terim angiograms for the presence or absence of a culprit lesion defined as
total occlusion, angiographic clot, lesion change :::50% or lesion>75% di-
ameter stenosis. Of 1253 enrolled patients with at least one SVG patent, 127
patients with clinical events and analyzable interim angiograms were evalu-
ated.
Results:
* none vs native vessel. t none vs graft, ** graft vs native vessel, p < 0.05
George T. Christakis, Karen Buth, Richard D. Weisel, Vivek Rao, Joan Ivanov,
Stephen E. Fremes. University of Toronto, Toronto, Ontario, Canada
Clinical indications for angiography differed depending on the anatomic
site of the culprit lesioR. Patients with graft culprit lesions more frequently
had MI (30.8%) than patients with culprit native vessel lesions (11.1 %) P <
0.05, or with no lesions (0%).
Conclusions: In Post-CABG patients with clinical events that necessitated
repeat angiography, only one-half had graft disease as the identifiable cause.
No responsible lesion was found in 12%. Treatment for symptomatic pa-
tients fOllowing coronary artery bypass surgery may differ substantially de-
pending on the anatomic cause of symptoms.
Females (F) present for CABG with a different demographic profile than
males (M) and have a higher incidence of mortality (OM) and low output syn-
drome (LOS). Females may not have the same predictors of OM and LOS as
males. This study was designed to assess the determinants of OM and LOS
for F and M proceeding to isolated CABG. Between 1990 and 1994 pre and
perioperative data were prospectively collected on 7,633 CABG patients (M
= 6168, F = 1465). Differences in preoperative risk variables between M and
F were assessed by univariate statistics. The fOllowing were significant (p <
0.05) gender differences: F were older (F = 64 ± 9, M = 60 ± 9). and had a
higher incidence of urgent surgery US (F = 22%, M = 14%). class IV symp-
toms (F = 53%, M = 36%), preoperative myocardial infarction PMI (F = 18%,
M = 14%, p = 0.001), diabetes OM (F = 31 %, M = 20%). hypertension (F =
62%, M = 46%). peripheral vascular disease PVD IF = 15%, M = 12%, P =
0.002). hypercholesterolemia (F = 57%, M = 51 %), smoking history SMa IF
= 52%, M = 77%). preoperative strokes (F = 9%, M ~ 6%, p = 0.001), sin-
gle vessel disease (F = 9%, M = 5%). left ventricular ejection fraction (LVEFI
>40% (F ~ 83%, M = 78%). Females had a lower incidence of reoperative
surgery REDO (F = 3.6%, M = 6.6%1. Postoperatively F had a higher (p <
0.001) incidence of OM (F = 3.5%, M = 1.8%). LOS (F = 15%, M = 6.6%),
and MIIF = 5.5%, M = 2.8%). The multivariable risk factors (odds ratios) for
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In terms of hospital rankings, there was generally close correlation be-
tween any two of the methods (Spearman's R = 0.87,0.88, and 0.93, com-
paring P-O, P-H, and H-O). Rankings for an individual hospital varied, how-
ever, an average of ±3.3 ranks (range 0-12 ranks) depending on which risk-
adjustment methodology was used.
Conclusion: In general. published methods of risk-adjustment for bypass
surgery accurately identify institutions with low, moderate and high adjusted
Health care payors and consumers have a growing interest in risk-adjusted
provider profiles. Using chart-abstracted clinical data from the Cooperative
Cardiovascular Project. we ranked 28 hospitals performing bypass surgery
in Alabama and Iowa by their risk-adjusted surgical mortality rates using
three published risk-adjustment methodologies: Parsonnet (PI, O'Connor (a)
and Hannan (H). In total. 3653 bypass surgery cases performed from 6/92
to 3/93 were reviewed (mean 130 cases/hospital). The discriminatory abili-
ties of each method for predicting surgical mortality were quite similar (area
under ROC curves 0.72-0.75). Below, we display the risk-adjusted hospital
rankings (comparing observed with expected mortality) by these three risk-
adjustment techniques:
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Do Females have the Same Risk Factors as Males
for CABG?
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